Skip to main content

Drug Prices: Effects of Opening Federal Supply Schedule for Pharmaceuticals Are Uncertain

HEHS-97-60 Published: Jun 11, 1997. Publicly Released: Jun 11, 1997.
Jump To:
Skip to Highlights

Highlights

GAO reviewed the factors that can affect negotiations for schedule drug prices and the potential effects of opening the pharmaceutical schedule on schedule prices available to federal, state, and local government purchasers. Although GAO reviewed economic and other assumptions used in these assessments, GAO did not validate the supporting data, such as drug prices and expenditures.

Full Report

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs

Public Inquiries

Topics

Cooperative agreementsDrugsFederal supply systemsHealth care programsHospitalsLocal governmentsPharmaceutical industryPrice regulationState and local procurementState governmentsMedicaid